The Australian healthcare sector has been the best performing sector of the Australian share market over the last couple of years, although this statistic masks considerable variability within the sector. The global leaders (CSL, Cochlear and Resmed) have driven the lion’s share of the sector’s outperformance over the last two... Show More
The prospect of a Labor government has far reaching ramifications for investors. However, there is one sector that stands to benefit from the election cycle whatever the result, says Matthew Haupt from Wilson Asset Management. Show More
While reporting season confirmed the continued strength of Australian corporates, private hospital operators were a stark exception, with fundamentals deteriorating due to two notable trends. We discuss these here, and look at Healthscope and Ramsay from a credit perspective. Show More
I recently attended the Brambles investor day in London. Prior to the investor day I scheduled some healthcare related meetings throughout Europe, including attending the International Plasma Protein Congress in Budapest. The healthcare meetings were with various industry participants including the offshore operations of Australian listed healthcare companies, their... Show More
This year saw outstanding results from the hospital operators, in particular, Ramsay Healthcare (RHC). Results were at the top end of consensus forecasts, and expectations are for continued robust growth. Over the last 20 year, RHC has produced an average of 16% compound earnings growth, and this looks like it... Show More
With reporting season in full swing, there are three companies to talk about today. 1300 Smiles a strong result, and Volpara is making progress is rolling out their Software As A Service platform. Finally, the big news is from Impedimed. They've officially launched their commercial version of their heart failure... Show More
SDI Ltd (ASX:SDI) is a developer, manufacturer and distributor of dental restorative materials and small dental equipment. With it’s suite of non-amalgam, significantly higher margin products - glass ionomers, composites and professional whitening - all experiencing growth, the company has guided to NPAT of $7.2-$7.8m in FY16 and is trading... Show More
Anton Tagliaferro, Investment Director at Investors Mutual, said in a recent investment update that they’re starting to take profits on some names in the healthcare sector. “The healthcare sector rallied partly because the Australian Dollar fell when the RBA cut rates. Many companies, like CSL, Sonic Healthcare, and Resmed, their... Show More
Whether we consider the last week, or the last 12months, the Australian Healthcare Sector remains a shining light on the local stock market. As would be expected there are some blemishes within the sector, with Ansell (ANN) and Primary Health Care (PRY) experiencing a disappointing 12 months. However, overall the... Show More
The pitch goes something like this: ‘People won’t stop getting sick in a downturn and operating earnings have risen for 20 consecutive years. Ramsay Health Care is recession proof. BUY’. Show More